PCAS - Release of the 2019 Universal Registration Document (URD) – Review of the trends for 2020
31 Mars 2020 - 6:08PM
PCAS - Release of the 2019 Universal Registration Document (URD) –
Review of the trends for 2020
Release of the 2019 Universal
Registration Document (URD) – Review of the trends for
2020
Ecully, March 31, 2020
The PCAS Universal Registration Document 2019,
which includes the annual financial report, was filed with France's
Financial Markets Authority on March 31, 2020, under number
D.20-0222.
This document contains:
- The 2019 annual financial report
- The Board of Directors' corporate governance report in
accordance with Section L.225-37 of France's Commercial
Code
- Information on the statutory auditors' fees
This document is now available:
- At PCAS headquarters: 21 chemin de la Sauvegarde, 21 Ecully
Parc, CS 33167, 69134 Ecully, France
- On the company website: www.pcas.com
The press release published on March 23
indicated that "in 2020, net sales and earnings are still expected
to improve on 2019, subject, of course, to the impacts of the
coronavirus, should the current crisis further continue".
The global health crisis relating to the
coronavirus is changing by the day, and there is still some
uncertainty around surrounding its duration, its extent and its
effects on companies' production lines and demand in general.
The PCAS Group has not seen any significant
impacts on its business activities and earnings at the present
time. However, it is hard to anticipate the potential impacts in
the medium term. This crisis calls for cautious measures, and due
to the exceptional circumstances, the Group is suspending its
financial targets and its strategic business objectives until the
situation becomes clearer.
|
NEXT FINANCIAL
DISCLOSURE: |
2020 Annual General Meeting in Massy at
2 pm on May 12, 2020 |
ABOUT PCAS
PCAS specializes in the development and
production of complex molecules for life sciences and innovative
technologies. With 10% of its net sales earmarked for R&D and a
large international footprint, PCAS is the preferred industrial
partner for market-leading major global groups. Boasting especially
high standards, the company offers a growing range of proprietary
products and solutions in leading-edge segments. PCAS generated net
sales of €200.9 million in 2019 and employs close to 1 100
people in six countries.
To find out more about PCAS: www.pcas.com
PCAS |
Newcap |
Pierre Luzeau / Eric Moissenot |
Emmanuel Huynh / Louis-Victor DelouvrierFinancial
communication and investor relations |
Tél. : +33 1 69 79 60 00 www.pcas.com |
Tél. : +33 1 44 71 98 53pcas@newcap.eu |
- PCAS - REL_URD_2019_REV_TRENDS_2020
PCAS (EU:PCA)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
PCAS (EU:PCA)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024